How should a man presenting with hematospermia be evaluated and managed?

Evaluation and Management of Hematospermia

Initial Assessment: Age-Based Stratification

For men under 40 years presenting with a single, asymptomatic episode of hematospermia, watchful waiting with reassurance is the appropriate management—no imaging is required. 1

The evaluation of hematospermia fundamentally depends on patient age, symptom persistence, and associated clinical features. The first critical step is confirming that blood truly originates from the patient's ejaculate rather than postcoital bleeding from a sexual partner. 1

Baseline Workup (All Ages)

When evaluation is warranted, obtain:

• Visual confirmation of blood in ejaculate 1
• Urinalysis and urine culture 1
• Semen analysis 1
• Complete blood count and coagulation studies 1
• Serum chemistry panel 1

Management Algorithm by Age and Clinical Presentation

Men < 40 Years Old

Single, transient episode without symptoms:

• No imaging indicated 1
• Provide reassurance that this represents a benign, self-limited condition that typically resolves within several weeks 1
• The ACR rates transrectal ultrasound as "usually not appropriate" (rating 3) in this scenario 1
• Malignancy risk is extraordinarily low (0.01% in one large claims database study) 2

Persistent/recurrent episodes OR associated symptoms:

• Proceed to imaging with transrectal ultrasound (TRUS) 1
• When infection is identified in this age group, it accounts for 40-55% of cases 1
• Consider sexually transmitted infection testing if lower urinary tract symptoms present 3

Men ≥ 40 Years Old

All patients in this age group require:

• Mandatory prostate cancer screening with PSA testing and digital rectal examination, regardless of whether another apparent cause exists 1
• TRUS as first-line imaging (ACR rating: "usually appropriate," rating 8) 1
• In this population, iatrogenic injury from prior urogenital instrumentation (especially prostate biopsy) is the most common identifiable cause 1
• Malignancy risk increases to 0.11% in patients ≥40 years 2

Critical pitfall: Do not omit PSA testing even when an obvious alternative cause (such as recent prostate biopsy) appears present. 1

Imaging Strategy

First-Line: Transrectal Ultrasound (TRUS)

TRUS is indicated for:

• All men ≥40 years with hematospermia 1
• Any age with persistent or recurrent episodes beyond several weeks 1
• Accompanying systemic symptoms (fever, chills, weight loss, bone pain) 1
• Lower urinary tract symptoms or abnormal digital rectal examination 1

TRUS performance:

• Demonstrates abnormalities in 82-95% of men with hematospermia 1
• Can identify prostatic calcifications, ejaculatory duct or seminal vesicle cysts, benign prostatic hyperplasia, and Cowper gland masses 1

Important caveat: Many TRUS findings (prostatic calcifications, benign prostatic hyperplasia, non-obstructing cysts) represent incidental age-related changes rather than the true cause of hematospermia. 1 These should not be presumed causative and do not preclude appropriate cancer screening. 1

Second-Line: MRI

MRI is indicated when:

• TRUS results are negative or inconclusive (ACR rating: "usually appropriate," rating 7-8) 1

MRI advantages over TRUS:

• Operator-independent acquisition 1
• Superior soft-tissue contrast 1
• High-resolution multiplanar anatomic evaluation 1
• Better delineation of organ of origin for midline/paramedian cysts 1
• More accurate assessment of ejaculatory duct obstruction 1
• Superior characterization of hemorrhage age and location within the seminal tract 1

Red-Flag Features Requiring Immediate Workup

Proceed with comprehensive evaluation regardless of age when:

• Persistent or recurrent hematospermia beyond several weeks 1
• Fever, chills, weight loss, or bone pain 1
• Dysuria or lower urinary tract symptoms 1
• Abnormal digital rectal examination 1
• New, non-reducible varicocele (constitutes a red-flag sign mandating immediate investigation) 1
• Elevated PSA levels 4

Common Etiologies by Age

Men < 40 Years

• Urogenital infections (most common identifiable cause, 40-55%) 1
• Prostatic or ejaculatory duct calcifications 1
• Seminal vesicle or ejaculatory duct cysts 1
• Idiopathic (majority of cases) 1

Men ≥ 40 Years

• Iatrogenic from urogenital instrumentation (most common identifiable cause) 1
• Benign prostatic hyperplasia 1
• Prostatic calcifications 1
• Ejaculatory duct obstruction 1
• Prostate cancer (must not be missed; accounts for 90.5% of malignancies detected) 4
• Idiopathic (51.8% in systematic review) 4

Treatment Approach

Management is directed at the underlying cause once identified:

• Antimicrobial therapy for documented infections 1
• Correction of coagulopathy if identified 1
• Urologic referral for persistent cases requiring vesiculoscopy (diagnostic accuracy 74.5% versus 45.3% for TRUS alone) 1
• Reassurance remains appropriate after thorough evaluation excludes serious pathology, even when no cause is identified 1

Natural history: In younger men, hematospermia typically resolves spontaneously within several weeks without specific intervention. 1 Spontaneous resolution occurs in 88.9% of cases with unknown etiology. 4

Critical Pitfalls to Avoid

• Do not order imaging in men <40 years with isolated transient hematospermia, as it adds unnecessary anxiety, cost, and may reveal incidental findings of unclear significance 1
• Do not assume prostatic calcifications or benign prostatic hyperplasia are causative; these are frequently incidental findings in asymptomatic men 1
• Do not omit PSA testing in men ≥40 years, even when another apparent cause exists 1
• Confirm blood originates from patient's ejaculate rather than partner before initiating workup 1

Special Diagnostic Situations

Ejaculatory duct obstruction:

• TRUS is specifically recommended when semen analysis suggests obstruction (acidic pH, azoospermia, low volume) with normal testosterone and palpable vas deferens 1

Vesiculoscopy utility:

• Particularly useful for detecting calculi and strictures at the verumontanum orifice or ejaculatory duct 1
• Combined use of vesiculoscopy and TRUS yields highest diagnostic accuracy 1